Renfeng Guo

Fortune : 3 M $ au 31/03/2024

53 ans

Consumer Services

Health Technology

Postes actifs de Renfeng Guo

Sociétés	Poste	Début	Fin
INFLARX N.V.	Director/Board Member	01/12/2007	-
	Chief Tech/Sci/R&D Officer	01/12/2007	-
	Founder	01/12/2007	-

Sociétés	Poste	Début	Fin
University of Michigan	Corporate Officer/Principal	01/01/2001	-
InflaRx GmbH InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany.	Director/Board Member	-	-
	Chief Tech/Sci/R&D Officer	11/12/2007	-
	Founder	25/11/2009	-

Norman Bethune Medical University

Doctorate Degree

Internationale

Opérationnelle

Sectorielle

Consumer Services	3
Health Technology	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
INFLARX N.V.	Health Technology

Entreprise privées	1
InflaRx GmbH InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany.	Health Technology

Entreprise privées

Health Technology